Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
PaperCitations, authors & open-access status
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 287 citations, 2011 year and diamond oa status.
287
Citations
2011
Year
diamond
OA Status